+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Release tests for indomethacin suppositories

Release tests for indomethacin suppositories

Yakuzaigaku 46(4): 276-282

The release tests for three commercial indomethacin suppositories of water-insoluble bases were carried out by two different methods, Muranishi method and Thomas modified method. For Muranishi method, the effects of the volume of release fluid in a cell, the pore size of membrane, and temperature on the drug release were studied. The drug release amount, in general, decreased with an increase in the fluid volume and with a decrease in the pore size but did not vary with temperature in the range of 37.0 to C. The effect of the fluid volume was presumed to be ascribed to an expanse (or dispersion) of suppository base, while one of the suppositories was emulsion-type and showed the release behavior somewhat different from that of other oleaginous base suppositories. On the other hand, the effect of the pore size was considered to be apparent because the pore volume of the membrane used (Millipore SSWP, AAWP, HAWP, and GSWP) decreases with a decrease in the pore size. For Thomas modified method, the effect of temperature on the drug release was studied. In contrast with the case of Muranishi method, the drug release amount increased with a rise in temperature. Further, the order of drug release of the three suppositories by Thomas modified method was different from that by Muranishi method.

(PDF 0-2 workdays service: $29.90)

Accession: 006306628

Download citation: RISBibTeXText

Related references

Preparation of sustained release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits. Chemical & Pharmaceutical Bulletin (Tokyo) 35(10): 4249-4254, 1987

Sustained release indomethacin: a double blind comparison with indomethacin suppositories. New Zealand Medical Journal 93(682): 261-262, 1981

Bioavailability of sustained release indomethacin suppositories containing polycarbophil. International Journal of Pharmaceutics (Amsterdam) 113(2): 209-213, 1995

Experimental study on sustained release suppositories of indomethacin. Chinese Journal of Pharmaceuticals 24(3): 114-116, 1993

Indomethacin sustained-release suppositories containing sugar ester. Chemical & Pharmaceutical Bulletin 38(4): 1027-1031, 1990

The effect of bases and formation on the release of indomethacin from suppositories. Drug Development & Industrial Pharmacy 12(11-13): 1813-1832, 1986

Formulation development and release studies of indomethacin suppositories. Indian Journal of Pharmaceutical Sciences 70(4): 498-501, 2008

Study on the release of indomethacin from suppositories: In vitro-in vivo correlation. International Journal of Pharmaceutics (Amsterdam) 85(1-3): 113-120, 1992

Kinetics of indomethacin release from suppositories in vitro in vivo correlation. International Journal of Pharmaceutics (Kidlington) 39(3): 235-242, 1987

Evaluation in biopharmaceutics of sustained-release suppositories of indomethacin in rabbits. Chinese Journal of Pharmaceuticals 24(10): 452-454, 1993

Sustained release dosage forms 1. preparation and bio availability of indomethacin suppositories. Chemical and Pharmaceutical Bulletin (Tokyo) 31(8): 2793-2798, 1983

Preparation and in vitro evaluation of sustained release suppositories containing microencapsulated indomethacin. Chemical & Pharmaceutical Bulletin (Tokyo) 35(3): 1201-1206, 1987

Study on slow release of indomethacin from suppositories containing hydrogenated soybean lecithin. Chemical & Pharmaceutical Bulletin (Tokyo) 36(9): 3696-3701, 1988

Influence of fat composition on the melting behaviour and on the in vitro release of indomethacin suppositories. International Journal Of Pharmaceutics (amsterdam). 85(1-3): 103-112, 1992

In vivo and in vitro release of indomethacin from water-soluble and fatty base suppositories. Acta Medica Okayama 46(4): 223-231, 1992